2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, OCTOBER 28, 2026 |
FMCPG HAS BEEN SERVING
AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY SINCE 2020 |
THE
"FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG) FOR ALL "MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY "
WHAT THE ELECTION MEANS FOR FLORIDA CANNABIS
CONTINUED DISCUSSION ON THE RESCHEDULING OF CANNABIS BY THE FEDERAL GOVT
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S AND PATIENT INPUT PORTALS ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
REF'S ISSUES AND SOLUTIONS
TIME TO RENEW YOUR MEMBER IN FMCPG
CLICK HERE FOR THE MEMBERSHIP FORM USE THIS LINK TO REGISTER FOR THE
NEXT MEETING
WEDNESDAY, NOVEMBER 11, 2026 CLICK ON LINK BELOW |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE FOR 2026 BY CANNABIS NEWS FLORIDA
ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $499 AND INCLUDES A ONE YEAR MEMBERSHIP IN THE FMCPG - MUST BE PUCHASED BEFORE 12/31/26 **Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100. IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
We want to apologize for the inconvenience caused by the recent technical issues affecting our ability to provide the current news updates, announcements, press releases, and information you rely on from the Florida Cannabis community.
As a result of these website-related issues, some of the latest news and updates have been delayed from appearing as scheduled in the Cannabis News Florida E-Newsletter.
Once the issues have been resolved, we will work to ensure that delayed news and updates are posted and shared with our readership.
We sincerely appreciate your patience, support, and understanding as we work through this unexpected interruption. Sometimes even the best systems need a little medical attention!
Thank you for being a valued reader of Cannabis News Florida E-Newsletter. We look forward to bringing you the latest news and information from Florida’s Cannabis community again very soon.
Thank you for your continued support and understanding. |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S
IN FLORIDA Click on Company Logo to be Transferred to Web Site
|
Curaleaf Responds to Alberta Securities Commission Decision
Oct. 27, 2026— Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf”), a leading international provider of consumer and medical cannabis products, today issued the following statement in response to the Alberta Securities Commission’s ruling regarding Aurora Cannabis Inc.’s (“Aurora“) at-the-market (“ATM“) program.
“Aurora would like shareholders to believe the ASC’s ruling changes the fundamental debate. It does not,” said Boris Jordan, Chairman of the Board and Chief Executive Officer of Curaleaf. “The questions confronting Aurora shareholders remain the same today as they were yesterday: why did Aurora issue shares under an ATM for less than the original offer price after Curaleaf indicated a bid was coming, why is a now 86% premium offer being dismissed as inadequate and a discounted offer, why is Curaleaf continuing to be excluded from customary diligence when others aren’t, and why is the Board asking shareholders to reject a proposal before allowing a fully informed process to play out? Those questions remain unanswered.”
READ MORE
|
INDIVA CANNABIS
M&V Investment One LLC and its affiliates (collectively, “M&V”) and Royal Group Resources Ltd. (“RGR”). SEVEN LOCATION IN FLORIDA
|
Cresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical Cannabis\
CHICAGO–OCTOBER 23, 2026 — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Prestonsburg in Kentucky, the Company’s 83rd dispensary nationwide.
Sunnyside is located at 81 Glynview Plaza, Prestonsburg, KY 41653.
Sunnyside’s opening marks a major milestone for Kentucky’s emerging medical cannabis program, with dispensaries now operating in all 11 regions of the Commonwealth for the first time.
“Access is the foundation of any successful medical cannabis program,” said Charlie Bachtell, CEO of Cresco Labs. “Kentucky continues to make meaningful progress, and we’re excited to help build on that momentum. For patients in Eastern Kentucky, this is an important step toward making medical cannabis a practical, accessible treatment option.”
READ MORE |
CURRENTLY OWED BY VIREO GROWTH INC.
|
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc. |
NATIONAL AND INTERNATIONAL NEWS |
Global Hemp Group Appoints Mickey Goldstein as Chief Financial Officer, Appoints Davidson & Company as Auditor
Vancouver, British Columbia – October 23, 2026 – Global Hemp Group Inc. (CSE: GHG) (FSE: GHG0) (OTC PINK: GBHPF) (“GHG” or the “Company“) is pleased to announce the appointment of Mickey Goldstein, CPA, CA, as Chief Financial Officer, effective immediately. Ms. Goldstein succeeds Christopher Cherry.
Ms. Goldstein is Director, Accounting Advisory at Crowe MacKay LLP, where she provides strategic financial and advisory services to private and public companies across North America. She brings particular depth in the mining and technology sectors, with experience in complex corporate transactions, including restructurings, acquisitions, and initial public offerings. Her practice also encompasses prospectus filings, public financings, and cross-border securities compliance.
Ms. Goldstein also serves as a fractional CFO for Canadian publicly listed companies, giving her direct experience with the operational, reporting, and governance demands of public-company management. Her background as a former public-company auditor, combined with her current executive-level advisory role, positions her to bridge technical accounting matters with practical strategic decision-making as the Company advances its next phase of growth.
READ MORE
|
Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity
New wholly owned subsidiary, led by Adrian Jones, to expand the Company’s network of clinics and pharmacies across Australia
New wholly owned subsidiary, led by Adrian Jones, to expand the Company’s network of clinics and pharmacies across Australia
VANCOUVER, British Columbia, Oct. 26, 2026 — Optimi Health Corp. (Nasdaq: OPTH, CSE: OPTI, FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical developer and manufacturer of regulated psychedelic drug products, today announced the establishment of Optimi Australia Pty Ltd (“Optimi Australia”), a wholly owned subsidiary responsible for distribution and business development in Australia, and the appointment of Adrian Jones as Director of Australian Operations.
Optimi Australia will handle the Company’s sales, distribution, and prescriber relationships across the country. It will sell Optimi’s finished drug products, 5mg naturally derived psilocybin capsules and 40mg and 60mg MDMA capsules, to clinics and pharmacies under Australia’s Authorised Prescriber Scheme. All products are manufactured at the Company’s Health Canada-licensed GMP facility in Princeton, British Columbia.
Mr. Jones joins Optimi after more than 15 years at Bristol Myers Squibb, most recently as Associate Director, Head of Sales and Marketing for its Australian oncology and cardiovascular portfolios, where he led national commercial teams and served as launch lead for first-in-class therapies including Opdivo and Camzyos. His early career includes psychiatry roles with Eli Lilly and Hospira.
READ MORE
|
CBD of Denver, Inc. Announces Operating Business Relaunch Following BioCannabis Agreement and New International Supply Contracts
Greece-based BioCannabis provides CBDD with an established European B2B operating platform, vertically integrated production capabilities and an expanding commercial customer base
Nea Apollonia, Greece– October 26, 2026) – CBD of Denver, Inc. (OTCID: CBDD) (“CBDD” or the “Company”) today announced continued progress in the relaunch and expansion of the operating business of BioCannabis M. IKE (“BioCannabis”), a Greece-based vertically integrated hemp and cannabinoid company with established business-to-business (“B2B”) wholesale operations and an expanding network of commercial customers.
CBDD entered into a definitive Share Exchange Agreement with BioCannabis on September 15, 2026. Since execution of the agreement, BioCannabis has continued to advance a number of operating and commercial milestones that formed part of the Company’s due-diligence process, including revenue generation, continued development of its production facility, expansion of its B2B distribution activities and the establishment of new supply relationships with international brands. The proposed transaction represents an important step in CBDD’s strategy to build a business supported by operating assets, commercial activity and recurring revenue opportunities in the European market.
READ MORE
|
HEMP LAW UPDATE: BEFORE CURRENT PROPOSAL
A massive federal hemp-THC ban is scheduled to take effect on November 12, 2026. Signed into law as part of the FY2026 Agriculture Appropriations Act, it redefines legal hemp to a 0.3% total THC limit (inclusive of THCA and delta-8) and caps final-form cannabinoid products at 0.4 mg of THC per container, rendering about 95% of current hemp-derived products federally unlawful. The situation remains highly fluid at both the federal and state levels: Federal Updates
The Ban Scope: The impending rules prohibit synthetic cannabinoids and those "synthesized or manufactured outside the plant," which directly impacts popular products like delta-8 THC, HHC, and most THCA flower.
White House Pushback: The White House has actively urged Congress to either delay the November 2026 implementation date or pass a fair regulatory framework to preserve access to full-spectrum CBD products.
Legislative Push: Various lawmakers, including Rep. Andy Barr, have pushed proposals to establish a legal regulatory pathway for domestic consumer hemp, though its fate remains undecided. State-Level & Local Enforcement
Texas Ban: Following a state Supreme Court ruling, Texas will start enforcing strict rules on July 31, 2026, effectively reclassifying and banning common consumer hemp derivatives (like delta-8 and THCP) from state shelves.
Missouri Lawsuit: Ahead of the November federal changes, Missouri enacted a state-level ban on intoxicating hemp products that is actively being challenged in federal court by hemp coalitions. Other States: States like New Jersey and Minnesota are actively passing legislation attempting to tightly integrate hemp products into their existing licensed, regulated cannabis frameworks. FLORIDA:
Florida's hemp market faces a massive collapse as the November 12, 2026, federal ban collides with intense local political maneuvering, strict state-level packaging rules, and a locked recreational cannabis market.
Because Florida's popular hemp-THC products currently average 1 to 10 milligrams of THC per container (such as those sold at mainstream retailers), the upcoming federal 0.4 mg cap is projected to eliminate nearly the entire state hemp sector. Political Battles and Veto History Past Governor Veto: Governor Ron DeSantis previously vetoed a strict state-level hemp ban, warning it would cause "dramatic disruption and harm" to small retail businesses.
Senate-House Deadlocks: During legislative sessions, lawmakers introduced bills like SB 438 to create 50 mg package caps. However, the House and Senate failed to agree on distribution rules, causing the state-level caps to die on the floor.
Federal Lobbying: Desperate to survive the impending November 2026 cliff, Florida hemp businesses are heavily lobbying Capitol Hill and pinning their remaining hopes on the Trump administration delaying the rule or amending the 0.4 mg cap. Both Florida Senators, Rick Scott and Marco Rubio, originally voted in favor of the federal restrictions.
Current State Rules & Active Enforcement
Total THC Testing Rules: The Florida Department of Agriculture and Consumer Services (FDACS) successfully defended its strict testing formula in court. Florida officially calculates compliance using Total THC (Delta-9 + 0.877 × THCA), rendering THCA flower highly restricted even before the federal ban hits.
Packaging Crackdown: State rules aggressively target and seize products featuring cartoon imagery or bright packaging. All items must utilize strict child-resistant locking mechanisms and include visible QR codes linking to official Certificates of Analysis (COAs).
Age Restrictions: Under active laws, you must be 21 or older to buy any ingestible or inhalable hemp extract. Newer 2026 legislation explicitly targets THC-infused beverages under the 21+ restriction.
The Broader Cannabis Landscape
The hemp industry's desperation is magnified by the status of traditional cannabis in the state. The Florida Supreme Court officially blocked the adult-use marijuana legalization initiative from the 2026 ballot due to a failure to meet signature verification rules. Because recreational cannabis remains completely dead for the 2026 cycle, hemp businesses cannot easily transition into state-licensed recreational dispensaries. Instead, the state's commercial market remains restricted to its tightly controlled, corporate medical marijuana registry.
|
Trump-Backed Hemp Bill Could Replace the Federal THC Ban With Actual Regulation
Posted in HEMP NEWS by Carlos Hermida
A new bipartisan bill would regulate and tax hemp-derived THC products instead of effectively banning most of them in November. For consumers, farmers and small businesses, that is a much better conversation to be having.
JULY 26, 2026 – Congress may have discovered a strange new idea: if adults are buying a popular product, perhaps the government should regulate it instead of banning almost all of it and acting surprised when an illegal market appears.
On July 22, 2026, Republican Rep. Andy Barr of Kentucky and Democratic Rep. Angie Craig of Minnesota introduced the Lawful Hemp Protection Act, also identified as H.R. 9830. The bill has support from the Trump administration and would create a federal regulatory system for consumable hemp products, including some hemp-derived THC products.
The proposal arrives just months before a major change in federal law is scheduled to take effect on November 12, 2026. Unless Congress acts, the new federal definition of hemp will impose a limit of just 0.4 milligrams of total THC per container and prohibit certain synthesized or non-naturally occurring cannabinoids. In practice, that could remove a huge portion of today’s hemp-derived cannabinoid products from the legal market.
The Lawful Hemp Protection Act would take a different approach: establish rules, require testing, restrict sales to adults, collect taxes and punish irresponsible operators.
In other words, regulate the industry like grown-ups.
READ MORE
|
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 942,000
AND 782 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
OCTOBER 16 2026 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) OCT 16, 2026- 942,952 OCT 09, 2026- 942,370 OCT 02, 2026- 941,963
SEP 25,2026- 941,616 SEP 18, 2026- 941, 650
SEP 11,2026- 941,271
Patients Last Week: +582
Qualified Ordering Physicians: 2,038
New Doctors Last Week: +6
Reporting Period: OCT 9, 2026 - OCT 15, 2026
Amount of Medical Marijuana Dispensed - (mgs THC) 416,298,831
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 910
Amount of Marijuana in a From for Smoking (oz) 149,377.953
Approved Dispensing Locations: 782 Added Last Week: 1 GTI Florida, LLC – Belleview |
UPCOMING MEETING AND CONFERENCES |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|
|